New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 18, 2014
10:57 EDTCREE, OPK, KING, PSEC, YPF, ICPT, ACRX, TAX, CALL, ARWROptions with decreasing implied volatility
Options with decreasing implied volatility: ARWR ICPT KING CALL YPF OPK TAX PSEC CREE ACRX
News For ARWR;ICPT;KING;CALL;YPF;OPK;TAX;PSEC;CREE;ACRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 31, 2015
10:03 EDTACRXHigh option volume stocks
High option volume stocks: MDCO IR TROV RLGY PAH XRX ACRX
07:11 EDTICPTIntercept announces NDA for OCA accepted for review by FDA
Subscribe for More Information
06:16 EDTPSECProspect Capital files $5B mixed securities shelf
Subscribe for More Information
August 28, 2015
11:04 EDTYPFOptions with increasing implied volatility
Subscribe for More Information
06:31 EDTTAXLiberty Tax reports Q1 adjusted EPS (65c), consensus (69c)
Subscribe for More Information
August 27, 2015
09:26 EDTPSECOn The Fly: Pre-market Movers
Subscribe for More Information
August 26, 2015
20:03 EDTPSECOn The Fly: After Hours Movers
Subscribe for More Information
16:55 EDTPSECProspect Capital reports Q4 EPS 25c, consensus 25c
Subscribe for More Information
09:15 EDTOPKOPKO CEO Frost issues letter to shareholders on Bio-Reference deal
OPKO Health (OPK) chairman and CEO Phillip Frost released a letter to shareholders regarding the recently announced acquisition of Bio-Reference Laboratories (BRLI). "The strategy behind the recent Bio-Reference acquisition is twofold. First, it is a business whose revenues and profits have grown consistently since its launch by Dr. Marc Grodman in the 1980's, primarily through organic growth, to become the third largest full service reference laboratory in the United States," the letter reads. "It has built a reputation of innovation with recognized franchises in women's health, cancer and, more recently, genetics, helping physicians worldwide to diagnose rare genetic disorders and to identify special features of a patient's genetic material to select more effective chemotherapy. Second, it provides an infrastructure for marketing and sales that reaches approximately 10M patients a year." The letter adds that the 4Kscore test confirms elevated PSA tests have reduced costs by roughly $1B and, if the costs of downstream treatment interventions are also considered, there could be $2.5B additional annual savings to the U.S. health care system. "Among the many compelling reasons for the acquisition, we believe Bio-Reference will greatly accelerate the commercial success of the 4Kscore test," the letter continues. "Bio-Reference has the capacity to dramatically increase the number of 4Kscore tests done each day. They provide national marketing and distribution with a large client services group and a large dedicated sales force that already have strong relationships with primary care physicians. Bio-Reference has over 1,200 phlebotomists and 180 blood-draw centers around the country that can facilitate patient access. Finally, Bio-Reference has robust billing operations and a seasoned national reimbursement team that participates in almost every major commercial insurance plan. Bio-Reference has the expertise and extensive infrastructure to help make the 4Kscore test the new standard for identifying aggressive prostate cancer in men with a suspicious PSA." To close the letter, Frost wrote, "Given Bio-Reference's historical seasonal trends, we expect the second half of 2015 to show continuing growth in earnings and profits. We further expect that the contributions of Bio-Reference, FineTech and EirGen, will create positive EBITDA, or earnings before interest, income taxes, depreciation and amortization, for OPKO. Finally, we expect to continue to invest in research and development activities which, if successful, will result in ongoing improvement of our financial performance."
07:09 EDTARWRVertex, Novavax among select biotechs to buy on weakness, says Piper Jaffray
Subscribe for More Information
August 24, 2015
10:37 EDTCALLMorgan Stanley reports 5.1% passive stake in magicJack
Subscribe for More Information
August 21, 2015
11:24 EDTTAXIntuit plummets after Q1, FY16 outlooks trail estimates
Shares of tax preparation software provider Intuit (INTU) are sinking after the company's first quarter and fiscal 2016 outlooks significantly trailed analyst's consensus estimates. WHAT'S NEW: After the close on Thursday, Intuit reported fourth quarter adjusted earnings per share of (5c) and revenue of $696M, compared to analysts' consensus estimates of (12c) and $738.98M, respectively. In the U.S., TurboTax Online units increased 11% and total TurboTax units grew 7%, excluding the Free File Alliance, the company said. Additionally, Intuit said it reached 1.075M QuickBooks Online subscribers through the end of Q4 and increased total QuickBooks online subscribers by 57% for the year. Brad Smith, Intuit's president and Chief Executive Officer said the company closed out fiscal year 2015 "on a strong note," adding that the company's small business momentum "continues to build and our QuickBooks Online ecosystem growth is accelerating." Looking ahead, Intuit said it expects Q1 adjusted EPS of (4c)-(3c) and revenue of $660M-$680M, well below analysts' consensus estimates of of 6c and $776.36M, respectively. For FY16, the company expects adjusted EPS of $3.40-$3.45 and revenue of $4.53B-$4.6B, far short of the consensus of $3.82 and $5.04B, respectively. WHAT'S NOTABLE: In its earnings release, Intuit announced its intent to divest Demandforce, QuickBase and Quicken. The divestment will help Intuit "focus on and invest in businesses that strengthen the ecosystem and align with two strategic goals: to be the operating system behind small business success, and to do the nations' taxes in the U.S. and Canada," the company said. As a result of the decision, the company said FY16 adjusted EPS will be reduced by about 10c and revenue will be reduced by approximately $250M, as the company reports these assets as discontinued operations. Separately, Intuit raised its dividend for the first quarter by 20% to 30c per share, payable on October 19. ANALYST REACTION: First Analysis analyst James Macdonald downgraded Intuit this morning to Underweight from Equal Weight. Macdonald said Intuit's small business online ecosystem has "relatively low monetization." PRICE ACTION: In late morning trading, Intuit fell $10.80, or 10.41%, to $92.23 on more than twice its average daily trading volume. Despite today's pull back, the shares have gained approximately 5% over the past year. OTHERS TO WATCH: Other companies in the tax preparation space include Liberty Tax (TAX), up 0.16%, and H & R Block (HRB), down 1.5%.
August 20, 2015
17:19 EDTOPKInnospec to replace Bio-Reference Labs in S&P 600 as of 8/21 close
OPKO Health (OPK) is acquiring Bio-Reference Laboratories (BRLI) in a deal that closed August 20.
10:43 EDTOPKOPKO Health completes acquisition of Bio-Reference Labs
Subscribe for More Information
10:28 EDTKINGOptions with decreasing implied volatility
Options with decreasing implied volatility: KING JCP URBN DKS JWN HIG ADI DAR LOW TJX
August 19, 2015
14:35 EDTOPKBio-Reference Labs to host special shareholder meeting
Special Shareholder Meeting to vote on the proposed merger with OPKO Health will be held in Mahwah, New Jersey on August 20 at 9 am.
12:20 EDTOPKOPKO Health enters agreements with provider networks for lab testing services
Subscribe for More Information
10:14 EDTKINGOptions with decreasing implied volatility
Options with decreasing implied volatility: KING SUNE YY JCP URBN NTES DKS DANG SINA KSS
August 18, 2015
10:19 EDTPSECOptions with increasing implied volatility
Subscribe for More Information
10:13 EDTCREE, KINGOptions with decreasing implied volatility
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use